Acta Ortopédica Mexicana

Mifsut‑Miedes D, Climent‑Péris V, Baeza‑Oliete J, Strauch‑Leira M, Álvarez‑Llanas A, Martínez‑Algarra JC, Valero‑Queralt MA, Ferraro‑Esparza L, Gilabert‑Dapena E, Gargallo‑Verge E
Blood-saving strategies in total primary knee replacement
Acta Ortop Mex 2019; 33 (3)

Language: Español
References: 41
Page: 150-156
PDF: 129.51 Kb.

[Fulltext - PDF]


Introduction: The objective of this study was to make an update on the different strategies in the blood saving in prosthetic primary knee surgery, through a bibliographical review; As well as to know what strategies are followed in different hospitals in our field, through a survey. Material and methods: We carried out a descriptive transversal observational study based on a survey of 64 surgeons and a bibliographical research on the different aspects included in the survey. Results: Surgeons refer that they have presurgical blood-saving protocols implanted in their Hospital at 48.4%. The use of tranexamic acid (ATX) is quite widespread 71.9% of respondents (46/64). It is administered intravenously prior to surgery in 26.6% of cases, intraarticularly by 21.9% and in a combination of both in 23.4%. The preferred time for the placement of ischemia by surgeons is 57.8% prior to painting the field, while a 39.1% prefer to place it in sterile conditions. 3.1% of surgeons claim to implant the prosthesis without using ischemia in surgery. Discussion: The use of ATX as the primary blood-saving strategy in TKR is being imposed. There is No consensus as to the optimal dose or its route of administration. The efficacy of the ATX is influencing the elimination of post-surgical drainage and the implementation of early rehabilitation programs.

Key words: Ischemia, tourniquet, tranexamic acid, bleeding, knee, prosthesis.


  1. Urban MK. Anestesia para la cirugía ortopédica. En: Miller RD. editors. Miller’s anesthesia. Philadelphia: Elsevier Churchill Livingstone, 2010.

  2. Zou S, Stramer SL, Dodd RY. Donor Testing and Risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations. Transfus Med Rev. 2012; 26(2): 119-28.

  3. Aguilera-Roig X, Jordán-Sales M, Natera-Cisneros L, Monllau-García JC, Martinez-Zapata MJ. Ácido tranexámico en cirugía ortopédica. Rev Esp Cir Ortop Traumatol. 2014; 58: 52-6.

  4. He P, Zhang Z, Li Y, Xu D, Wang H. Efficacy and safety of tranexamic acid in bilateral total knee replacement: a meta-analysis and systematic review. Med Sci Monit. 2015; 21: 3634-42.

  5. Saleh KJ, Santos ER, Ghomrawi HM, Parvizi J, Mulhall KJ. Socieconomic issues and demographics in total knee arthroplasty revision. Clin Orthop Relat Res. 2006; 446: 15-21.

  6. Paxton EW, Furnes O, Namba RS, Inacio MC, Fenstad AM, Havelin LI. Comparison of the Norwegian knee arthroplasty register and a United States arthroplasty registry. J Bone Joint Surg Am. 2011; 93(Suppl. 3): 20-30.

  7. Bisbe E, Sáez N, Nomen N, Castillo J, Santiveri X, Mestre C, et ál. Eritropoyetina, sola o como coadyuvante del programa de donación de sangre autóloga en cirugía ortopédica mayor. Rev Esp Anestesiol Reanim. 2003; 50: 395-400.

  8. Couvret C, Tricoche S, Baud A, Dabo B, Bouchet S, Palud M, et ál. The reduction of preoperative autologous blood donation for primary total hip or knee arthroplasty. The effect of subsequent rates. Anesth Analg. 2002; 94(4): 815-23.

  9. Bierbaum B, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999; 81(1): 2-10.

  10. Niskanen RO, Korkala OL, Haapala J, Kuokkanen HO, Kaukonen JP, Salo SA. Drainage is of no use in primary uncomplicated cemented hip and knee arthroplasty for osteoarthritis. J Arthroplasty. 2000; 15(5): 567-9.

  11. Parker MJ, Roberts CP, Hay D. Closed suction drainage for hip and knee arthroplasty. a meta-analysis. J Bone Joint Surg Am. 2004; 86(6): 1146-52.

  12. Carless PA, Henry DA, Money AJ, O’Connell DL, Fergusson DA. Coll salvage for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2006; (4): CD001888.

  13. Rubens FD, Boodhwani M, Lavaleer G, Mesana T. Perioperative red blood cell salvage. Can J Anaesth, 2003; 50(Suppl: 6): S31-40.

  14. Slappendel R, Dirksen, Weber EW, Van der Schaal DB. An algorithm to reduce allogeneic red blood cell transfusions for major orthopedic surgery. Acta Orthop Stand. 2003; 74(5): 569-75.

  15. Manso MF, Galindo PM, Peraza SM, Gonzalez FI, Ramos GF, Castro UA. Autotransfusión postoperatoria en la cirugía protésica primaria de rodilla. Red Esp Anestesiol. 2004; 51: 316-21.

  16. Moreno ZE, Echenique EM, Emparanza KJ, Usabiaga ZJ. Cirugía sin sangre en las prótesis totales de rodilla. Rev Esp Cir Ortop Traumatol. 2008; 52(06): 372-80.

  17. López-Anglada E, Paz-Aparicio J, Bertrand D, Gosálbez J, Núñez-Batalla D, Paz-Jiménez J. Influencia de la aprotinina en el sangrado postoperatorio de la artroplastía total de rodilla. Rev Esp Cir Ortop Traumatol. 2005; 49(6): 421-8.

  18. Camarasa MA, Olle G, Serra-Prat M, Martín A, Sanchez M, Ricós P, et ál. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth. 2006; 96(5): 576-82.

  19. Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, et ál. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology. 2006; 105(5): 1034-46.

  20. Leal-Noval SR, Muñoz M, Asuero M, Contreras E, García Erce JA, Llau JV, et ál. Documento Sevilla de Consenso sobre alternativas a la transfusión de sangre alogénica. Actualización del documento Sevilla. Rev Esp Anestesiol Reanim. 2013; 60: 263.e1-e25.

  21. Canillasa F, Gómez-Ramírez S, García-Erce JA, Pavía-Molina J, Gómez-Luque A, Muñoz M. Patient blood management en cirugía ortopédica. Rev Esp Cir Ortop Traumatol. 2015; 59(3): 137-49.

  22. Ficha técnica Amchafibrin 500mg solución inyectable. Disponible en:

  23. AAOS. Surgical management of osteoarthritis of the knee. Evidence- based clinical practice guideline. Disponible en: http:/ K%20CPG 12.4.15.pdf.

  24. Kozek-Langenecker SA, Afshari A, Albadalejo P, Santullano CA, de Robertis E, Filipescu DC, et ál. Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013; 30(6): 270-82.

  25. Goldstein M, Feldmann C, Wulf H, Wiesmann T. Tranexamic acid prophylaxis in hip and knee joint replacement. Dtsch Arzteb Int. 2017; 114(48): 824-30.

  26. Hourlier H, Fennema P. Single tranexamic acid dose to reduce perioperative morbidity in primary total hip replacement: a Randomized clinical trial. Hip Int. 2014, 24(1): 63-8.

  27. Castro-Menéndez M, Pena-Paz S, Rocha-García F, Rodríguez-Casas N, Huici-Izco R, Montero-Viéites A. Eficacia de 2 gramos intravenosos de ácido tranexámico en la reducción del sangrado postoperatorio de la artroplastía total de cadera y rodilla. Red Esp Cir Ortop Traumatol. 2016; 60(5): 315-24.

  28. Oremus K, Sostaric S, TrkuljaV, Haspl M. Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial. Transfusion. 2014; 54(1): 31-41.

  29. Hsu CH, Lin PC, Kuo FC, Wang JW. A regime of two intravenous injections of tranexamic acid reduces blood loss in minimally invasive total hip arthroplasty. Bone Joint J. 2015; 97-B(7): 905-10.

  30. Rajesparan K, Biant LC, Ahmad M, Field RE. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br. 2009; 91(6): 776-83.

  31. Sanz-Reig J, Parra-Ruiz B, Ferrández-Martínez J, Martínez-López JF. Dosis única intravenosa de ácido tranexámico como medida de ahorro transfusional en prótesis total primaria de rodilla. Red Esp Cir Ortop Traumatol. 2016; 60(2): 106-12.

  32. Chen Y, Chen Z, Cui S, Li Z, Yuan Z. Topical versus systemic tranexamic acid after total knee and hip arthroplasty: a meta-analysis of randomized con- trolled trials. Medicine (Baltimore). 2016; 95(41): e4656.

  33. Li JF, Li H, Zhao H, Wang J, Liu S, Song Y, Wu HF. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017; 12(1): 22.

  34. Barr PJ, Donnelly M, Cardwell C, Alam SS, Morris K, Parker M, et ál. Drivers of transfusion decision making and quality of the evidence in orthopedic surgery: a systematic review of the literature. Transfus Med Rev. 2011; 25(4): 304-16.

  35. Noordin S, Waters TS, Garbuz DS, Duncan CP, Masri BA. Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty. Clin Orthop Relat Res. 2011; 469(2): 541-6.

  36. Carling MS, Jeppsson A, Eriksson BI, Brisby H. Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J Orthop Surg Res. 2015; 10: 48.

  37. Li Y, Lu M, Tian H, Li ZJ, Zhang K. Effect of different tourniquet releasing strategy on blood loss in total knee arthroplasty. Zhonghua Yi Xue Za Zhi. 2017; 97(41): 3219-24.

  38. Schnetter T, Papillon N, Rees H. Use of a tourniquet in total knee arthroplasty causes a paradoxical increase in total blood loss. J Bone Joint Surg. 2017; 99(16): 1331-6.

  39. Park JH, Choi SW, Shinn EH, Park MH, Kim MK. The optimal protocol to reduce blood loss and blood transfusion after unilateral total knee replacement: low-dose IA-TXA plus 30-min drain clamping versus drainage clamping for the first 3 h without IA-TXA. J Orthop Surg (Hong Kong). 2017; 25(3): 2309499017731626.

  40. Tang Q, Ping S, Gang Z, Hua-Zi X, Hai-Xiao L. Extramedullary versus intramedullary femoral alignment technique in total knee arthroplasty: a meta-analysis of randomized controlled trials. J Orthop Surg Res. 2017; 12(1): 82.

  41. Yu z, Yao L, Yang Q. Tranexamic acid plus diluted-epinephrine versus tranexamic acid alone for blood loss in total joint arthroplasty. Medicine (Baltimore). 2017; 96(24): e7095.